Improving cognitive function in the elderly

人口老龄化已被确定为当代澳大利亚社会面临的主要问题之一。对澳大利亚来说，人类老龄化带来了重大的社会、经济代价，更重要的是，带来了个人/人类代价。与老龄化相关的经济成本反映了生产力下降以及各种疾病的发病率增加，包括心血管和呼吸系统疾病，重要的是，神经系统疾病，如帕金森病（PD）和阿尔茨海默病（AD）。我们将完成两项大规模的研究，检查两种维生素活性补充剂在减少老年参与者老化认知影响方面的12个月管理的有效性。

The ageing population has been identified as one of the major issues facing contemporary Australian society. For Australia, human ageing has significant societal, economic and, importantly, personal/human costs. The economic costs associated with ageing reflect decreased productivity as well as a higher incidence of a variety of illnesses including cardiovascular and respiratory disease and, importantly, neurological conditions such as Parkinson's disease (PD) and Alzheimer's disease (AD). We will complete two large scale studies examining the efficacy of twelve months administration of two pharmacologically active supplements in reducing the cognitive effects of aging in elderly participants.